Company Filing History:
2 out of 21 
2 out of 541 
Years Active: 2022-2024
Title: David Rodney Ungar: Innovator in Antibody Drug Conjugates
Introduction
David Rodney Ungar is a notable inventor based in Murray Hill, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of Antibody Drug Conjugates (ADCs) for cancer treatment. With a total of 2 patents to his name, Ungar's work is paving the way for innovative therapeutic approaches.
Latest Patents
Ungar's latest patents focus on dosage regimes for the administration of an anti-CD19 ADC. The present disclosure relates to the treatment of pathological conditions, such as cancer, using ADCs that specifically bind to CD19. This innovative approach aims to enhance the efficacy of cancer treatments by optimizing the administration of these targeted therapies.
Career Highlights
Throughout his career, David Rodney Ungar has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Adc Therapeutics SA and MedImmune Limited. His experience in these organizations has contributed to his expertise in the development of advanced therapeutic solutions.
Collaborations
One of his notable coworkers is Jay Marshall Feingold. Their collaboration has likely fostered innovative ideas and advancements in the field of ADCs.
Conclusion
David Rodney Ungar's contributions to the field of medicine through his patents and collaborations highlight his role as an innovator in cancer treatment. His work continues to influence the development of targeted therapies that hold promise for improving patient outcomes.